Raise a Voice, an advocacy group for advanced prostate cancer patients, which is calling for patient access to drugs that have passed through Phase I trials, has written a thank you letter to the FDA Advisory Committee on Dendreon’s sipuleucel-T (Provenge).

The letter is signed by 19 prostate cancer advocacy groups including US Too International and National Prostate Cancer Coalition.